Monkey Pox Clinical Trial
Official title:
Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities
The study team will create an online module via the REDCap platform. The module will include around 5 videos and several infographics covering the topics of symptoms, transmission, prevention, vaccination, and treatment of the monkeypox virus. Surveys assessing the primary and secondary study endpoints will be given to participants before and after the module. The purpose of the study is to assess the efficacy and acceptability of an educational presentation on monkeypox in a cohort of individuals recruited from Rainbow Health and to secondarily assess participant risk perception, intention to vaccinate, and confidence in public health initiatives.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05567939 -
Clinical, Virological, Immunological, Psychosocial and Epidemiological Consequences of Human Monkeypox Virus (ProMPX)
|
||
| Completed |
NCT05543577 -
Assessing the Preparedness and Knowledge of Pharmacists in the Current Monkeypox Outbreak
|
||
| Not yet recruiting |
NCT05922735 -
Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users
|
||
| Recruiting |
NCT05947786 -
Mpox Paediatric and Adolescent Clinical Study
|
||
| Completed |
NCT05443867 -
Monkeypox ASymptomatic Shedding: Evaluation by Self-Sampling MPX-ASSESS
|
||
| Active, not recruiting |
NCT05438953 -
Follow-up of People at Risk of Monkeypox Infection: a Prospective Cohort Study
|
N/A | |
| Recruiting |
NCT05627713 -
Clinical and Biological Aspects of the MONKEYPOX Disease
|
N/A | |
| Recruiting |
NCT05698082 -
FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues
|
Phase 2/Phase 3 | |
| Completed |
NCT00728689 -
Phase I Trial of an Investigational Small Pox Medication
|
Phase 1 |